Evidence map›Paper›PMID 32848719›Full record

ArticleFrontiers in pharmacology2020

Yuanxia Cui, Hao Yan, Yi Su, Lifang Wang, Tianlan Lu, Dai Zhang, Weihua Yue

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Journal of personalized medicine · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yuanxia CuiInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Hao YanInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Yi SuInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Lifang WangInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Tianlan LuInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Dai ZhangInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Weihua YueInstitute of Mental Health, Peking University Sixth Hospital, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Institute for Brain Research · CNPeking University · CNPeking University Sixth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to provide dose recommendations for risperidone in Asian people based on cytochrome P450 enzyme

Indexed as

CYP2D6cytochrome P-450pharmacogeneticspolymorphismrisperidone

Identifiers

PMID32848719
PMCPMC7417932
OpenAlexW3047372839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.